The aim of this study was to investigate the expression rate of TROP2 in PC and CC and evaluate the efficacy of PIT with TROP2‐IR700 in vitro and in vivo for TROP2‐expressing PC and CC cell lines. The gene discussed is TACSTD2; the disease is cholangiocarcinoma.